DOPAMINE AGONISTS

Novel compounds which are selective dopamine agonists are useful for treating disorders characterized by abnormal dopamine levels, such as Parkinson's Disease, as well as cardiovascular disorders.

Saved in:
Bibliographic Details
Main Authors RICHARD J. PERNER, JAMES R. CAMPBELL, MICHAEL P. DENINNO, PAUL P. EHRLICH, JOHN F. DEBERNARDIS, LINDA M. LIJEWSKI, ROBERT W. SCHOENLEBER, DAVID M. STOUT, YVONNE C. MARTIN, JOHN W. KEBABIAN, STANLEY DIDOMENICO JR, CHI-NUNG W. HSIAO, BISWANATH DE, HOWARD E. MORTON, FATIMA Z. BASHA, MICHEAL D. MEYER
Format Patent
LanguageEnglish
Published 07.01.1991
Edition5
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract Novel compounds which are selective dopamine agonists are useful for treating disorders characterized by abnormal dopamine levels, such as Parkinson's Disease, as well as cardiovascular disorders.
AbstractList Novel compounds which are selective dopamine agonists are useful for treating disorders characterized by abnormal dopamine levels, such as Parkinson's Disease, as well as cardiovascular disorders.
Author YVONNE C. MARTIN
MICHEAL D. MEYER
JAMES R. CAMPBELL
FATIMA Z. BASHA
MICHAEL P. DENINNO
PAUL P. EHRLICH
JOHN W. KEBABIAN
STANLEY DIDOMENICO JR
CHI-NUNG W. HSIAO
HOWARD E. MORTON
RICHARD J. PERNER
DAVID M. STOUT
LINDA M. LIJEWSKI
BISWANATH DE
ROBERT W. SCHOENLEBER
JOHN F. DEBERNARDIS
Author_xml – fullname: RICHARD J. PERNER
– fullname: JAMES R. CAMPBELL
– fullname: MICHAEL P. DENINNO
– fullname: PAUL P. EHRLICH
– fullname: JOHN F. DEBERNARDIS
– fullname: LINDA M. LIJEWSKI
– fullname: ROBERT W. SCHOENLEBER
– fullname: DAVID M. STOUT
– fullname: YVONNE C. MARTIN
– fullname: JOHN W. KEBABIAN
– fullname: STANLEY DIDOMENICO JR
– fullname: CHI-NUNG W. HSIAO
– fullname: BISWANATH DE
– fullname: HOWARD E. MORTON
– fullname: FATIMA Z. BASHA
– fullname: MICHEAL D. MEYER
BookMark eNrjYmDJy89L5WQQdPEPcPT19HNVcHT39_MMDgnmYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXxjqGmFoYWRpYGjsaEVQAAbnEe0w
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Edition 5
ExternalDocumentID AU5818290A
GroupedDBID EVB
ID FETCH-epo_espacenet_AU5818290A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:24:06 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU5818290A3
Notes Application Number: AU19900058182
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19910107&DB=EPODOC&CC=AU&NR=5818290A
ParticipantIDs epo_espacenet_AU5818290A
PublicationCentury 1900
PublicationDate 19910107
PublicationDateYYYYMMDD 1991-01-07
PublicationDate_xml – month: 01
  year: 1991
  text: 19910107
  day: 07
PublicationDecade 1990
PublicationYear 1991
RelatedCompanies ABBOTT LABORATORIES
RelatedCompanies_xml – name: ABBOTT LABORATORIES
Score 2.4084835
Snippet Novel compounds which are selective dopamine agonists are useful for treating disorders characterized by abnormal dopamine levels, such as Parkinson's Disease,...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title DOPAMINE AGONISTS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19910107&DB=EPODOC&locale=&CC=AU&NR=5818290A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTW0TEwBlny6KUag0apESyNdSzMLE11g5Z2WYmFikmgEHszx9TPzCDXxijCNYGLIgO2FAZ8TWg4-HBGYo5KB-b0EXF4XIAaxXMBrK4v1kzKBQvn2biG2Lmop0O1iwARmYK7m4mTrGuDv4u-s5uwM7Emq-QXZmgIrJiNLA0dmBlZgI9oclBdcw5xAe1IKkCsUN0EGtgCgWXklQgxMqXnCDJzOsHvXhBk4fKHT3UAmNOcVizAIuvgHOPp6-rkqOLr7-3kGhwSLMsi7uYY4e-gCzY6HeyPeMRTmCGMxBhZg5z5VgkHBLMkwycgsLSnZJDHRJMnMNMnYMM0cKGJolpiYbJ6YIskggcsUKdxS0gxckCVNQGQuw8BSUlSaKgusPEuS5MD-BgAEgXEf
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTW0TEwBlny6KUag0apESyNdSzMLE11g5Z2WYmFikmgEHszx9TPzCDXxijCNYGLIgO2FAZ8TWg4-HBGYo5KB-b0EXF4XIAaxXMBrK4v1kzKBQvn2biG2Lmop0O1iwARmYK7m4mTrGuDv4u-s5uwM7Emq-QXZmgIrJiNLA0dmBlZgA9sclBdcw5xAe1IKkCsUN0EGtgCgWXklQgxMqXnCDJzOsHvXhBk4fKHT3UAmNOcVizAIuvgHOPp6-rkqOLr7-3kGhwSLMsi7uYY4e-gCzY6HeyPeMRTmCGMxBhZg5z5VgkHBLMkwycgsLSnZJDHRJMnMNMnYMM0cKGJolpiYbJ6YIskggcsUKdxS8gycHiG-PvE-nn7e0gxckOVNQGQuw8BSUlSaKgusSEuS5MBhAAB79nQS
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=DOPAMINE+AGONISTS&rft.inventor=RICHARD+J.+PERNER&rft.inventor=JAMES+R.+CAMPBELL&rft.inventor=MICHAEL+P.+DENINNO&rft.inventor=PAUL+P.+EHRLICH&rft.inventor=JOHN+F.+DEBERNARDIS&rft.inventor=LINDA+M.+LIJEWSKI&rft.inventor=ROBERT+W.+SCHOENLEBER&rft.inventor=DAVID+M.+STOUT&rft.inventor=YVONNE+C.+MARTIN&rft.inventor=JOHN+W.+KEBABIAN&rft.inventor=STANLEY+DIDOMENICO+JR&rft.inventor=CHI-NUNG+W.+HSIAO&rft.inventor=BISWANATH+DE&rft.inventor=HOWARD+E.+MORTON&rft.inventor=FATIMA+Z.+BASHA&rft.inventor=MICHEAL+D.+MEYER&rft.date=1991-01-07&rft.externalDBID=A&rft.externalDocID=AU5818290A